LR-5182 is a stimulant drug which acts as a norepinephrine-dopamine reuptake inhibitor structurally related to the better known drug fencamfamine. It was developed by the pharmaceutical company Eli Lilly in the 1970s and researched for potential use as an antidepressant although never marketed.
This page contains content from the copyrighted Wikipedia article "LR-5182"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
